The global urinary catheters market size accounted for US$ 5.90 billion in 2023 and is projected to reach around USD 10.15 billion by 2033, growing at a CAGR of 5.57% from 2024 to 2033.
Key Points
- North America has accounted for more than 35% of the market share in 2023.
- By product, the intermittent catheters segment dominated the market with the largest market share of 58% in 2023.
- By application, the Urinary Incontinence (UI) segment dominated the market with the largest share of 38% in 2023.
- By type, the coated catheters segment led the market in 2023.
- By gender, the women segment led the market in 2023 and promises sustained growth during the forecast period.
- By end-user, the hospitals segment led the market with the largest share in 2023.
Report Summary
The global urinary catheters market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the urinary catheters market across the globe.
A comprehensive estimate on the urinary catheters market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of urinary catheters during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3908
Urinary Catheters Market Scope
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 5.57% |
Global Market Size in 2023 | USD 5.90 Billion |
Global Market Size by 2033 | USD 10.15 Billion |
U.S. Market Size in 2023 | USD 1.55 Billion |
U.S. Market Size by 2033 | USD 2.66 Billion |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Product, By Application, By Type, By Gender, and By End-user |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized urinary catheters market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Outboard Engines Market Size to Hit USD 18.12 Bn by 2033
Market Players
The report includes the profiles of key urinary catheters market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In January 2023, after a thorough authorization procedure, Bactiguard announced the approval of its first MDR (Medical Device Regulations 2017/745) product. The latex BIP Foley Catheter, an indwelling urinary catheter using Bactiguard’s exclusive infection prevention technology, is the subject of the MDR approval. A thin coating of noble metal alloy affixed to the catheter’s surface serves as the foundation for Bactiguard’s unique technology. The metals have a galvanic effect when they come into contact with fluids, which lowers microbial adhesion—that is, fewer germs stick to the catheter surface. Healthcare-associated infections (HAI) impact one in ten patients globally, with catheter-associated urinary tract infections (CAUTI) accounting for a sizable portion of cases. The incidence of CAUTI is considerably decreased by urinary catheters equipped with Bactiguard technology.
- In December 2022, to minimize urinary tract infections (UTIs) and unintentional Foley catheter extractions, CATHETRIX, a creative creator of urinary (Foley) smart catheter fixation devices, commercially debuted their catheter stabilizer at the Arab Health 2023.
Urinary Catheters Market Companies
- Coloplast
- ConvaTec, Inc.
- Boston Scientific Corp.
- BD (C.R. Bard, Inc.)
- Cook Medical
- Medtronic PLC
- Teleflex, Inc.
- B. Braun Melsungen AG
- Hollister, Inc.
- Medline Industries, Inc.
- J and M Urinary Catheters LLC
Segments Covered in the Report
By Product
- Foley/ Indwelling Catheters
- Intermittent Catheters
- External Catheters
By Application
- Urinary Incontinence
- Benign Prostate Hyperplasia & Prostate Surgeries
- Spinal Cord Injury
- Others
By Type
- Coated Catheters
- Uncoated Catheters
By Gender
- Male
- Female
By End-user
- Clinics
- Hospitals
- Long-Term Care Facilities
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Urinary Catheters Market
5.1. COVID-19 Landscape: Urinary Catheters Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Urinary Catheters Market, By Product
8.1. Urinary Catheters Market Revenue and Volume, by Product, 2024-2033
8.1.1. Foley/ Indwelling Catheters
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Intermittent Catheters
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. External Catheters
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Urinary Catheters Market, By Application
9.1. Urinary Catheters Market Revenue and Volume, by Application, 2024-2033
9.1.1. Urinary Incontinence
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Benign Prostate Hyperplasia & Prostate Surgeries
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Spinal Cord Injury
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Urinary Catheters Market, By Type
10.1. Urinary Catheters Market Revenue and Volume, by Type, 2024-2033
10.1.1. Coated Catheters
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Uncoated Catheters
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Urinary Catheters Market, By Gender
11.1. Urinary Catheters Market Revenue and Volume, by Gender, 2024-2033
11.1.1. Male
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Female
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Urinary Catheters Market, By End-user
12.1. Urinary Catheters Market Revenue and Volume, by End-user, 2024-2033
12.1.1. Clinics
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Hospitals
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
12.1.3. Long-Term Care Facilities
12.1.3.1. Market Revenue and Volume Forecast (2021-2033)
12.1.4. Others
12.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global Urinary Catheters Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.1.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.6.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.1.6.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.7.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.7.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.1.7.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.2.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.7. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.2.8. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.9.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.10. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.2.11. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.12.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.12.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.2.13. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.14.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.14.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.2.15. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.3.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.6.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.3.7. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.8.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.8.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.3.9. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.10.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.10.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.3.10.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.11.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.11.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.3.11.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.4.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.6.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.4.7. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.8.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.8.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.4.9. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.10.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.10.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.4.10.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.11.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.11.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.4.11.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.5.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.6.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.5.7. Market Revenue and Volume Forecast, by End-user (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.8.3. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.8.4. Market Revenue and Volume Forecast, by Gender (2021-2033)
13.5.8.5. Market Revenue and Volume Forecast, by End-user (2021-2033)
Chapter 14. Company Profiles
14.1. Coloplast
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. ConvaTec, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Boston Scientific Corp.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. BD (C.R. Bard, Inc.)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cook Medical
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Medtronic PLC
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Teleflex, Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. B. Braun Melsungen AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Hollister, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Medline Industries, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com